Pill Form of Semaglutide Fails to Slow Alzheimer's in Large Trial

The drug was safe but did not slow disease progression
Los Angeles, USA - April 4, 2023 Novo Nordisk only editorial Stock information on the logo of the office facade
Adobe Stock
Published on
Updated on
Loading content, please wait...

Related Stories

No stories found.
logo
www.healthday.com